Two Companies’ Antibodies Don’t Work Against Omicron, FDA Says
Two Companies’ Antibodies Don’t Work Against Omicron, FDA Says

Two Companies’ Antibodies Don’t Work Against Omicron, FDA Says

Business Wars Daily

31.01.2022 • 2 Min.

Today is Monday, January 31, and we're looking at Regeneron and Eli Lilly vs. GlaxoSmithKline. Listen ad free with Wondery+. Join Wondery+ for exclusives, binges, early access, and ad free listening. Available in the Wondery App. https://wondery.app.link/bwdaily See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.